Hyperbaric oxygen therapy in the management of nonhealing wounds in patients with critical limb ischemia

Therapy

Volumn 5, Issue 1, 2008, Pages 99-108

  Uzun, Gunalp ^a   Yildiz, Senol ^a   Aktas, Samil ^b  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Chronic wound; Hyperbaric oxygenation; Peripheral arterial disease; Transcutaneous oximetry; Wound healing

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; COLLAGEN; GENTAMICIN; GLUCOSAMINE DERIVATIVE; HEMOGLOBIN; MESSENGER RNA; NITRIC OXIDE; NITROFURANTOIN; OXYGEN; PLACEBO; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; RECOMBINANT PLATELET DERIVED GROWTH FACTOR; SULFONAMIDE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANGIOGENESIS; BACTERICIDAL ACTIVITY; BAROTRAUMA; CELL PROLIFERATION; CLINICAL TRIAL; COLLAGEN SYNTHESIS; DEBRIDEMENT; DIABETIC FOOT; DRUG POTENTIATION; EPITHELIZATION; FIBROBLAST; GANGRENE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPERBARIC OXYGEN; LEUKOCYTE; LIMB AMPUTATION; LIMB ISCHEMIA; LIMB PAIN; LUNG TOXICITY; METABOLIC REGULATION; MYOPIA; NEUROTOXICITY; NONHUMAN; OXYGEN TOXICITY; PATIENT SELECTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REST; REVIEW; TREATMENT DURATION; WOUND CARE; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

EID: 38349145552     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.2217/14750708.5.1.99     Document Type: Review

References (70)

1. Dormandy J. Verstraete M, Andreani D et al.: Second European consensus document on chronic critical leg ischemia. Circulation 84 (Suppl. 4), 1-26 (1991).
2. Santilli JD, Sntilli SM: Chronic critical limb ischemia: diagnosis, treatment and prognosis. Am. Fam. Physician 59(7), 1859-1908 (1999).
3. Eslami MH, Zayaruzny M, Fitzgerald GA: The adverse effects of race, insurance status, and low income on the rate of amputation in patients presenting with lower extremity ischemia. J. Vasc. Surg. 45(1), 55-59 (2007).
4. Sheikh AY, Gibson JJ, Rollins MD, Hopf HW Hussain Z, Hunt TK: Effect of hyperoxia on vascular endothelial growth factor levels in a wound model. Arch. Surg. 135(11), 1293-1297 (2000).
5. Faglia E, Favales F. Aldeghi A et al.: Change in major amputation rate in a center dedicated to diabetic foot care during the 1980s: prognostic determinants for major amputation. J. Diabetes Complicat. 12(2), 96-102 (1998).
6. Siddiqui A, Davidson JD, Mustoe TA: Ischemic tissue oxygen capacitance after hyperbaric oxygen therapy: a new physiologic concept. Plast. Reconstr. Surg. 99(1), 148-155 (1997).
7. Feldmeler JJ: Hyberbaric oxygen 2003: indications and results. The Hypberbaric Oxygen Committee Report. Feldmeier JJ (Ed.), Undersea and Hyperbaric Medical Society, Kensington, MD. USA (2003).
8. Kessier L, Bilbault P. Ortega F et al.: Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: a prospective randomized study. Diabetes Care 26(8), 2378-2382 (2003).
9. Bacharach JM, Rooke TW, Osmundson PJ, Gloviczki P: Predictive value of transcutaneous oxygen pressure and amputation success by use of supine and elevation measurements. J. Vasc. Surg. 15(3), 558-563 (1992).
10. Detmar M, Brown LF, Berse B et al.: Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J. Invest. Dermatol. 108, 263-268 (1997).
11. Tandara AA, Mustoe TA: Oxygen in wound healing - more than a nutrient. World J. Surg. 28(3), 294-300 (2004).
12. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359(6398), 843-845 (1992).
13. Siddiqui A, Galiano RD, Connors D, Gruskin E, Wu L. Mustoe TA: Differential effects of oxygen on human dermal fibroblasts: acute versus chronic hypoxia. Wound Repair Regen. 4, 211-218 (1996).
14. Kivisaari J, Nitnikoski J: Effects of hyperbaric oxygenation and prolonged hypoxia on the healing of open wounds. Arta Chir. Scand. 141(1), 14-19 (1975).
15. Gimbel M, Hunt T. Wound Healing and Hyperbaric Oxygenation. In: Hyperbaric medicine practice. (2nd edition- Revised). Kindwall EP, Whelan HT (Eds). Best Publishing Company, Flagstaff, AZ, USA, 169-204 (2002).
16. Jonsson K, Jensen JA, Goodson WH 3rd et al.: Tissue oxygenation, anemia, and perfusion in relation to wound healing in surgical patients. Ann. Surg. 214, 605-613 (1991).
17. Hopf HW, Humphrey LM, Puzziferri N, West JM, Attinger CE, Hunt TK: Adjuncts to preparing wounds for closure: hyperbaric oxygen, growth factors, skin substitutes, negative pressure wound therapy (vacuum-assisted closure). Foot Ankle Clin. 6(4), 661-682 (2001).
18. Sheffield PJ: Problem Wounds: The role of oxygen. Davis JC, Hunt TK, (Eds), Elsevier, NY, USA, 17-52 (1988).
19. Niklas A. Brock D, Schober R, Schulz A, Schneider D: Continuous measurements of cerebral tissue oxygen pressure during hyperbaric oxygenation - HBO effects on brain edema and necrosis after severe brain trauma in rabbits. J. Neurol. Sci. 219(1-2), 77-82 (2004).
20. Boykin JV Jr: Hyperbaric oxygen therapy: a physiological approach to selected problem wound healing. Wounds 8(6), 183-198 (1996).
21. Hehenberger K, Brismar K, Lind F, Kratz G: Dose-dependent hyperbaric oxygen stimulation of human fibroblast proliferation. Wound Repair Regen. 5. 147-150 (1997).
22. Piepmeier EH, Kalns JE: Fibroblast response to rapid decompression and hyperbaric oxygenation. Aviat. Space. Environ. Med. 70(6), 589-593 (1999).
23. Tompach PC, Lew D, Stoll JL: Cell response to hyperbaric oxygen treatment. Int. J. Oral Maxillofac. Surg. 26(2), 82-86 (1997).
24. Roberts CF. Harding KG: Stimulation of glycosaminoglycan synthesis In cultured fibroblasts by hyperbaric oxygen. Br. J. Dermatol. 131(5), 630-633 (1994).
25. Dimitrijevich SD, Paranjape S, Wilson JR, Gracy RW, Mias JG: Effect of hyperbaric oxygen on human skin cells in culture and in human dermal and skin equivalents. Wound Repair Regen. 7(l), 53-64 (1999).
26. Hopf HW. Gibson JJ, Angeles AP et al.: Hyperoxia and angiogenesis. Wound Repair Regen. 13(6), 558-564 (2005).
27. Cheadle WG: Risk factors for surgical site infection. Surg. Infect. (Larchmt.) 7 (Suppi. 1), S7-S11 (2006).
28. Allen DB, Maguire JJ, Mahdavian M et al.: Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch. Surg. 132(9), 491-996 (1997).
29. Mader JT Brown GL, Guckian JC, Wells CH, Reinarz JA: A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J. Infect. Dis. 142. 915-922 (1980).
30. Walden WC, Hentges DJ: Differential effects of oxygen and oxidation-reduction potential on the multiplication of three species of anaerobic intestinal bacteria. Appl. Microbiol. 30(5), 781-785 (1975).
31. Farr SB, Toutai D, Kogoma T: Effects of oxygen stress on membrane functions in Echerichia coli. role of HPI catalase. J. Bacteriol. 170(4), 1837-1842 (1988).
32. Hassan HM, Fridovich I: Superoxide radical and the oxygen enhancement of the toxicity of paraquat in Escherichia coli. J. Biol. Chem. 253(22), 8143-8148 (1978).
33. Stevens DL, Bryant AE, Adams K, Mader JT: Evaluation of therapy with hyperbaric oxygen for experimental infection with Clostridium perfringens. Clin. Infect. Dis. 17 (2), 231-237 (1993).
34. Kaye D: Effect of hyperbaric oxygen on Clostridia in vitro and in vivao. Proc. Soc. Exp. Biol. Med. 124(2), 360-366 (1967).
35. Demello FJ. Hashimoto T Hitchcock CR, Haglin JJ: The Effects of Hyperbaric Oxygen on Germination and Toxin Production of Clostridium perfringens Spores. In: Proceedings ofthe Fourth International Corgress on Hyperbaric Medicine. Wade J, Iwa JT (Eds), Williams & Wilkins Co., Baltimore, MD, USA, 276 (1970).
36. Pakman LM: Inhibition of Pseudomonas aeruginosa by hyperbaric oxygen. I. Sulfonamide activity enhancement and reversal. Infect. Immun. 4, 479-487 (1971).
37. Park MK, Muhvich KH, Myers RA. Marzella L: Hyperoxia prolongs the aminoglycoside-Induced postantiblotic effect in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 35, 691-695 (1991).
38. Muhvich KH, Park MK, Myers RA, Marzella L: Hyperoxia and the antimicrobial susceptibility of Escherichia coli and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 33, 1526-1530 (1989).
39. Mendel V. Reichert B, Simanowski HJ, Scholz HC: Therapy with hyperbaric oxygen and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats. Undersea Hyperb. Med. 26, 169-174 (1999).
40. 2 and a local antibiotic carrier for experimental osteomyelitis due to Staphylacocrus aureus in rats. Undersea Hyperb. Med. 31, 407-416 (2004).
41. Zhao LL, Davidson JD, Wee SC. Roth SI, Mustoe TA: Effect of hyperbaric oxygen and growth factors on rabbit ear ischemic ulcers. Arch. Surg. 129(10), 1043-1049 (1994).
42. 2 and PDCF. Undersea Hyperb. Med. 25 (4). 211-216 (1998).
43. Luo JD, Chen AF: Nitric oxide: a newly discovered function on wound heating. Acta Pharmacol. Sin. 26(3), 259-264 (2005).
44. Boykin JV Jr: Re: Oxygen in wound healing: more than a nutrient. Wound Repair Regen. 9(5), 391-392 (2001).
45. Boykin JV Jr, Baylis C: Hyperbaric oxygen therapy mediates increased nitric oxide production associated with wound healing: a preliminary study. Adv. Skin Wound Care 20(7), 382-388 (2007).
46. 2. Am. J. Physiol. 272, C770-C777 (1997).
47. Hong JP, Kwon H, Chung YK, Jung SH: The effect of hyperbaric oxygen on ischemia-reperfusion injury: an experimental study in a rat musculocutaneous flap. Ann. Plast. Surg. 51, 478-487 (2003).
48. Kolvenbach R, Kreissig C, Ludwig E, Cagiannos C: Stem cell use in critical limb ischemia. J. Cardiovasc. Surg. (Torino) 48(1), 39-44 (2007).
49. Tateishi-Yuyama E, Matsubara H, Murohara T et al.: Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360(9331), 427-435 (2002).
50. Thom SR, Bhopale VM, Velazquez OC, Goldstein LJ, Thom LH, Buerk DC: Stem cell mobilization by hyperbaric oxygen. Am. J. Physiol. Heart Circ. Physiol. 290(4), H1378-H1386 (2006).
51. Goldstein LJ, Gallagher KA, Bauer SM et al.: Endothelial progenitor cell release into circulation is triggered by hyperoxia-induced increases in bone marrow nitric oxide. Stem Cells 24(10), 2309-2318 (2006).
52. Baroni G, Porro T, Faglia E et al.: Hyperbaric oxygen in diabetic gangrene treatment. Diabetes Care 10, 81-94 (1987).
53. Urayama H, Takemura H, Kasajima et al.: Hyperbaric oxygen therapy for chronic occlusive disease of the extremities. Nippon Geka Gakkai Zasshi 93, 429-433 (1992).
54. Zamboni WA, Wong HP, Stephenson LL, Pfeifer MA: Evaluation of hyperbaric oxygen for diabetic wounds: a prospective study. Undersea Hyperb. Med. 24, 175-179 (1997).
55. Abidia A, Laden G, Kuhan G et al.: The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. Eur. J. Vasc. Endovasc. Surg. 25(6), 513-518 (2003).
56. Kalani M, Jorneskog G, Nazanin N, Lind F, Brismar K: Hyperbaric oxygen therapy in the treatment of diabetic foot ulcers. Longterm follow-up. J. Diabetes Complicat. 16, 153-158 (2002).
57. Caselli A, Latini V, Lapenna A et al.: Transcutaneous oxygen tension monitoring after succesful revascularization in diabetic patients with ischemic foot ulcers. Diabet. Med. 22(4), 460-465 (2005).
58. Wattel F, Mathieu D, Coget JM, Billard V: Hyperbaric oxygen therapy in chronic vascular wound management. Angiology 41(1), 59-65 (1990).
59. Faglia E, Favales F, Aldeghi A et al.: Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care 19(12), 1338-1343 (1996).
60. Smart DR, Bennett MH, Mitchell SJ: Transcutaneous oximetry, problem wounds and hyperbaric oxygen therapy. Diving Hyperb. Med. 36, 72-86 (2006).
61. Matos L, Nunez A: Enhancement of Healing in Selected Problem Wounds. In: Hyperbaric Medicine Practice (2nd Edition). Kindwall EP, Whelan HT (Eds). Best Publishing, Flagstaff, AZ, USA, 814-850 (2002).
62. Grolman RE, Wilkerson DK, Tavlor J, Allinson P, Zatina MA: Transcutaneous oxygen measurements predict a beneficial response to hyperbaric oxygen therapy in patients with nonhealing wounds and critical limb ischemia. Am. Surg. 67(11), 1072-1079; discussion 1080 (2001).
63. Smith BM, Desvigne LD, Slade JB, Dooley JW, Warren DC: Transcutaneous oxygen measurements predict healing of leg wounds with hyperbaric therapy. Wound Repair Regen. 4(2), 224-229 (1996).
64. Fife CE, Buyukcakir C, Otto GH et al.: The predictive value of transcutaneous oxygen tension measurement in diabetic lower extremity ulcers treated with hyperbaric oxygen therapy: a retrospective analysis of 1144 patients. Wound Repair Regen. 10(4), 198-207 (2002).
65. Fife CE, Buyukcakir C, Otto G, Sheffield P, Love T, Warriner R 3rd: Factors influencing the outcome of lower-extremity diabetic ulcers treated with hyperbaric oxygen therapy. Wound Repair Regen. 15(3), 322-331 (2007).
66. Plafki C, Peters P, Almeling M, Welslau W, Busch R: Complications and side effects of hyperbaric oxygen therapy. Aviat. Space Environ. Med. 71(2), 119-124 (2000).
67. Evanger K, Haugen OH, Irgens A, Aanderud L, Thorsen E: Ocular refractive changes in patients receiving hyperbaric oxygen administered by oronasal mask or hood. Acta Ophthalmol. Scand. 82(4), 449-453 (2004).
68. Yildiz S, Aktas S, Cimsit M, Ay H, Togrol E: Seizure incidence in 80,000 patient treatments with hyperbaric oxygen. Aviat. Space Environ. Med. 75(11), 992-994 (2004).
69. Thorsen E, Aanderud L, Aasen TB: Effects of a standard hyperbaric oxygen treatment protocol on pulmonary function. Eur. Respir. J. 12, 1442-1445 (1998).
70. Kranke P, Bennett M, Roeckl-Wiedmann I, Debus S: Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst. Rev. (2), CD004123 (2004).